Your browser doesn't support javascript.
loading
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Ichihashi, Kayo; Hori, Hikaru; Hasegawa, Naomi; Yasuda, Yuka; Yamamoto, Tomoya; Tsuboi, Takashi; Iwamoto, Kunihiro; Kishimoto, Taishiro; Horai, Tadasu; Yamada, Hiroki; Sugiyama, Nobuhiro; Nakamura, Toshinori; Tsujino, Naohisa; Nemoto, Kiyotaka; Oishi, Satoru; Usami, Masahide; Katsumoto, Eiichi; Yamamori, Hidenaga; Tomita, Hiroaki; Suwa, Taro; Furihata, Ryuji; Inagaki, Takahiko; Fujita, Junichi; Onitsuka, Toshiaki; Miura, Kenichiro; Matsumoto, Junya; Ohi, Kazutaka; Matsui, Yuki; Takaesu, Yoshikazu; Hashimoto, Naoki; Iga, Junichi; Ogasawara, Kazuyoshi; Yamada, Hisashi; Watanabe, Koichiro; Inada, Ken; Hashimoto, Ryota.
Affiliation
  • Ichihashi K; Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan.
  • Hori H; Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Hasegawa N; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Yasuda Y; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Yamamoto T; Life Grow Brilliant Mental Clinic, Foster Corporation, Osaka, Japan.
  • Tsuboi T; Department of Pharmacy, Osaka University Hospital, Suita, Japan.
  • Iwamoto K; Department of Neuropsychiatry, Kyorin University School of Medicine, Mitaka, Japan.
  • Kishimoto T; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Horai T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Yamada H; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Sugiyama N; Department of Psychiatry, Showa University, Tokyo, Japan.
  • Nakamura T; Department of Applied Occupational Therapy, Shinshu University School of Health Sciences, Matsumoto, Japan.
  • Tsujino N; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nemoto K; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
  • Oishi S; Department of Neuropsychiatry, School of Medicine, Toho University, Tokyo, Japan.
  • Usami M; Department of Psychiatry, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan.
  • Katsumoto E; Department of Psychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Yamamori H; Department of Psychiatry, Kitasato University, School of Medicine, Sagamihara, Japan.
  • Tomita H; Department of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Suwa T; Clinical Center for Children's Mental Health, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Furihata R; Katsumoto Mental Clinic, Osaka, Japan.
  • Inagaki T; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Fujita J; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Onitsuka T; Japan Community Health Care Organization, Osaka Hospital, Osaka, Japan.
  • Miura K; Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Matsumoto J; Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ohi K; Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.
  • Matsui Y; Adolescent Mental Health Service, Biwako Hospital, Otsu, Japan.
  • Takaesu Y; Department of Psychiatry, Shiga University of Medical Science, Otsu, Japan.
  • Hashimoto N; Department of Child Psychiatry, Yokohama City University Hospital, Yokohama, Japan.
  • Iga J; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ogasawara K; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Yamada H; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Watanabe K; Department of Psychiatry and Psychotherapy, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Inada K; Department of General Internal Medicine, Kanazawa Medical University, Uchinada, Japan.
  • Hashimoto R; Department of Psychiatry, Jindai Hospital, Toyota, Japan.
Neuropsychopharmacol Rep ; 40(3): 281-286, 2020 09.
Article in En | MEDLINE | ID: mdl-32602667
ABSTRACT

BACKGROUND:

Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project aimed to standardize medical practice using quality indicators (QIs) as indices to evaluate the quality of medical practice. In this study, we have reported the quality indicator values of prescription before the beginning of the guideline lectures in the EGUIDE project to ascertain the baseline status of treating patients with schizophrenia.

METHODS:

A cross-sectional, retrospective case record survey was conducted, involving 1164 patients with schizophrenia at the time of discharge. We checked all types and dosage of psychotropic drugs.

RESULTS:

Forty-three percent of patients had antipsychotic polypharmacy, and substantial concomitant medication was observed (antidepressants; 8%, mood stabilizers 37%, anxiolytics or hypnotics 68%).

CONCLUSIONS:

In the results obtained in this study, we plant to report changes in the effectiveness of education in the EGUIDE project near the future.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychiatry / Schizophrenia / Practice Patterns, Physicians' / Practice Guidelines as Topic / Quality Indicators, Health Care / Prescriptions Type of study: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Neuropsychopharmacol Rep Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychiatry / Schizophrenia / Practice Patterns, Physicians' / Practice Guidelines as Topic / Quality Indicators, Health Care / Prescriptions Type of study: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Neuropsychopharmacol Rep Year: 2020 Document type: Article Affiliation country: